Many studies have implicated cPLA2 in mediating several disease processes in the nervous system, including post-ischemic brain injury, spinal cord injury (SCI), and neurodegenerative diseases (Chen, 2012; David et al., 2012; Leslie, 2015; Sarkar and Lipinski, 2023). The gene discussed is PLA2G4A; the disease is neurodegenerative disease.